Financials

  • Market Capitalization 437.75 M
  • Employee 73
  • Founded 2005
  • CEO Jason Okazaki
  • Website www.assemblybio.com
  • Headquarter Delaware, United States
  • FIGI BBG000R62Q06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-61.84
Rapporto prezzo/fatturato
5.27

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2907
RZLT
Rezolute, Inc. - Common Stock
4.73 USD-2.87%+6.53%+13.16%-39.75%457.50 M USD
2918
YDES
YD Bio Limited - Ordinary Shares
6.22 USD-1.74%+13.09%+55.11%-66.20%440.31 M USD
2924
ENTX
Entera Bio Ltd. - Ordinary Shares
2.57 USD-3.02%-1.53%-8.54%+0.78%444.97 M USD
2943
SLN
Silence Therapeutics Plc - American Depository Share
9.31 USD-3.52%-6.81%-27.60%+65.66%439.87 M USD

Notizie